Impact Stories | Vaccine


Researchers from the University of Ottawa and The Ottawa Hospital have been awarded $1,050,000 million from the Ca

Pfizer and Moderna announced in recent days that they have vaccine candidates that are over 90 pe

Researchers from McGill University are part of an international team led by the University of Buffalo, which has

New research suggests that the impact of natural and vaccine-induced immunity will be key factors in shaping the future trajectory of the global cor

Vaccination is the most effective public health measure to prevent infectious diseases.

It’s a thrilling process, akin to running a marathon, hundreds of researchers race alongside to find a cure or a vaccine.

Dr. Doug Mahoney, PhD, has spent a lifetime working with viruses.

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac)

This content is available in French only.